Join to View Full Profile
213 Quarry RoadPalo Alto, CA 94304
Phone+1 650-736-4310
Fax+1 650-725-0390
Dr. Dunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Dunn is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. He received his medical degree from Temple University School of Medicine and has been in practice 28 years. He specializes in neuroimmunology/multiple sclerosis and is experienced in neuroimmunology (multiple sclerosis).
Education & Training
University of WashingtonResidency, Neurology, 1990 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1989
Haverford CollegeBA, French Literature, 1979 - 1983
Certifications & Licensure
CA State Medical License 2008 - 2027
WA State Medical License 1990 - 2008
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis Start of enrollment: 2024 Apr 10
- Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Publications & Presentations
PubMed
- EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis.Shady Younis, Sajede Rasouli, Jacob W Loeffler, Neda Sattarnezhad, Ya'el Courtney
Biorxiv. 2026-02-12 - 1 citationsMajor depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics.Nathanael J Lee, Gavin Hui, C William Pike, Kristin Galetta, Lucas B Kipp
Frontiers in Neurology. 2025-01-01 - 7 citationsSingle-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort.Thanaphong Phongpreecha, Kavita Mathi, Brenna Cholerton, Eddie J Fox, Natalia Sigal
Molecular Neurodegeneration. 2024-08-01
Authored Content
- The Emergence of Chimeric Antigen Receptor T (CAR-T) Immunotherapy for Multiple Sclerosis: Review From ACTRIMS 2026February 2026
- Clonally expanded B cells in Multiple Sclerosis bind EBV EBNA1 and GlialCAMJanuary 2022
Press Mentions
AAN 2025: CAR T-cell Therapy for MS Shows Safety, Efficacy in TrialsApril 15th, 2025- ‘Military Police’ Cells Arise to Arrest Infection-Induced Autoimmunity, Study FindsMarch 8th, 2022
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017
Committees
- Chair, MS Section American Academy of Neurology 2018 - Present
- NMSS, National Medical Advisory Board 2018 - Present
Research History
- Principal InvestigatorProject BIG: The Brain, Immune & Gut Research Initiative to find the cause and cure of Multiple Sclerosis2018 - Present
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
